Masif Hemoptizi
Özet
Masif hemoptizi, trakea, bronşiyal sistem ve akciğer parankimi kaynaklı, hayatı tehdit edici boyuttaki kan tükürmedir. Kanama miktarına göre çeşitli nicel tanımlamalar bulunsa da, ortak bir konsensüs olmamakla birlikte günümüzde hastanın yaşamını tehlikeye atan ve asfiksiye yol açabilecek kanamalar fonksiyonel olarak bu şekilde tanımlanmaktadır. Vakaların %90'ı bronşiyal arter sisteminden köken alır. Klinikte en sık karşılaşılan etiyolojik nedenler bronşektazi, tüberküloz, fungal enfeksiyonlar (özellikle aspergilloma) ve akciğer neoplazmlarıdır. Hastaya yaklaşımda öncelik, havayolu güvenliğinin ve hemodinamik stabilizasyonun sağlanmasıdır. Tanısal süreçte akciğer grafisi, bilgisayarlı toraks tomografisi (BT) ve fiberoptik bronkoskopi (FOB) temel araçlardır. FOB, yatak başı uygulanabilirliği ve kanamayı lokalize etme yeteneğiyle öne çıkarken, BT altta yatan patolojiyi saptamada üstündür. Definitif tedavide, minimal invaziv bir yöntem olan bronşiyal arter embolizasyonu (BAE) aktif kanamayı hızla kontrol altına almak için birincil yöntem olarak kullanılır. Lokalize hastalıklarda ise kesin çözüm cerrahi rezeksiyondur. Ancak acil cerrahi yüksek mortalite taşıdığından, öncelikle BAE veya bronkoskopik yöntemlerle kanamanın kontrol altına alınması ve ardından elektif cerrahiye geçilmesi önerilir. Masif hemoptizi, multidisipliner bir yaklaşım gerektiren medikal bir acildir.
Massive hemoptysis is defined as life-threatening expectoration of blood originating from the trachea, bronchial tree, or lung parenchyma. Although various definitions exist based on bleeding volume, there is no consensus; thus, a functional definition focuses on the risk of asphyxia and threat to patient survival. Approximately 90% of cases originate from the bronchial arterial system. The most common clinical etiologies include bronchiectasis, tuberculosis, fungal infections (specifically aspergilloma), and lung neoplasms. Initial management strictly prioritizes airway stabilization and hemodynamic control. Diagnostic strategies rely on chest X-ray, computed tomography (CT), and fiberoptic bronchoscopy (FOB). FOB is critical for bedside localization of bleeding, whereas CT is superior in identifying the underlying pathology. Regarding definitive treatment, bronchial artery embolization (BAE) serves as the primary, minimally invasive intervention to achieve rapid hemostasis. In localized diseases, surgical resection offers a definitive cure. Since emergency surgery carries significantly high mortality, the recommended approach is to control the hemorrhage first via BAE or bronchoscopic methods, followed by elective surgery. Ultimately, massive hemoptysis is a critical medical emergency requiring a well-coordinated, multidisciplinary management strategy.
Referanslar
Amirana, M., et al., An aggressive surgical approach to significant hemoptysis in patients with pulmonary tuberculosis. American Review of Respiratory Disease, 1968. 97(2): p. 187-192.
Corey, R. and K.M. Hla, Major and massive hemoptysis: reassessment of conservative management. The American journal of the medical sciences, 1987. 294(5): p. 301-309.
Knott-Craig, C.J., et al., Management and prognosis of massive hemoptysis Recent experience with 120 patients. The Journal of thoracic and cardiovascular surgery, 1993. 105(3): p. 394-397.
Hirshberg, B., et al., Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. Chest, 1997. 112(2): p. 440-444.
Crocco, J.A., et al., Massive hemoptysis. Archives of internal medicine, 1968. 121(6): p. 495-498.
Yoon, W., et al., Bronchial and nonbronchial systemic artery embolization for life-threatening hemoptysis: a comprehensive review. Radiographics, 2002. 22(6): p. 1395-1409.
Jean-Baptiste, E., Clinical assessment and management of massive hemoptysis. Critical care medicine, 2000. 28(5): p. 1642-1647.
Mori, H., et al., Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients. Respiration, 2010. 80(1): p. 24-31.
Holsclaw, D.S., R.J. Grand, and H. Shwachman, Massive hemoptysis in cystic fibrosis. The Journal of pediatrics, 1970. 76(6): p. 829-838.
Garzon, A.A., M.M. Cerruti, and M.E. Golding, Exsanguinating hemoptysis. The Journal of thoracic and cardiovascular surgery, 1982. 84(6): p. 829-833.
Bobrowitz, I.D., S. Ramakrishna, and Y.-S. Shim, Comparison of medical v surgical treatment of major hemoptysis. Archives of internal medicine, 1983. 143(7): p. 1343-1346.
Johnston, H. and G. Reisz, Changing spectrum of hemoptysis: underlying causes in 148 patients undergoing diagnostic flexible fiberoptic bronchoscopy. Archives of internal medicine, 1989. 149(7): p. 1666-1668.
Brinson, G.M., et al., Bronchial artery embolization for the treatment of hemoptysis in patients with cystic fibrosis. American journal of respiratory and critical care medicine, 1998. 157(6): p. 1951-1958.
Gourin, A. and A.A. Garzon, Operative treatment of massive hemoptysis. The Annals of thoracic surgery, 1974. 18(1): p. 52-60.
Haponik, E.F., A. Fein, and R. Chin, Managing life-threatening hemoptysis: has anything really changed? Chest, 2000. 118(5): p. 1431-1435.
Chun, J.-Y., R. Morgan, and A.-M. Belli, Radiological management of hemoptysis: a comprehensive review of diagnostic imaging and bronchial arterial embolization. Cardiovascular and interventional radiology, 2010. 33(2): p. 240-250.
Remy, J., M. Remy-Jardin, and C. Voisin, Endovascular management of bronchial bleeding. Lung biology in health and disease, 1992. 57: p. 667-723.
MacIntosh, E.L., J.C. Parrott, and H.W. Unruh, Fistulas between the aorta and traceobronchial tree. The Annals of thoracic surgery, 1991. 51(3): p. 515-519.
Håkanson, E., et al., Management of life‐threatening haemoptysis. British journal of anaesthesia, 2002. 88(2): p. 291-295.
Pearse, E. and A. Bryan, Massive haemoptysis 27 years after surgery for coarctation of the aorta. Journal of the Royal Society of Medicine, 2001. 94(12): p. 640-641.
Cauldwell, E.W., The bronchial arteries an anatomic study of 150 human cadavers. Surg. Gynecol. Obstet., 1948. 86: p. 359-412.
Sancho, C., et al., Embolization of bronchial arteries of anomalous origin. Cardiovascular and interventional radiology, 1998. 21(4): p. 300-304.
Cohen, A.M., C.F. Doershuk, and R. Stern, Bronchial artery embolization to control hemoptysis in cystic fibrosis. Radiology, 1990. 175(2): p. 401-405.
Butler, J., Clinical aspects of the bronchial circulation. Lung biology in health and disease, 1992. 57: p. 477-491.
Marshall, T. and J. Jackson, Vascular intervention in the thorax: bronchial artery embolization for haemoptysis. European radiology, 1997. 7(8): p. 1221-1227.
Deffebach, M.E., et al., The bronchial circulation: small, but a vital attribute of the lung. American Review of Respiratory Disease, 1987. 135(2): p. 463-481.
Furuse, M., et al., Bronchial arteries: CT demonstration with arteriographic correlation. Radiology, 1987. 162(2): p. 393-398.
Do, K.-H., et al., Systemic arterial supply to the lungs in adults: spiral CT findings. Radiographics, 2001. 21(2): p. 387-402.
Pump, K., The bronchial arteries and their anastomoses in the human lung. Diseases of the Chest, 1963. 43(3): p. 245-255.
McDONALD, D.M., Angiogenesis and remodeling of airway vasculature in chronic inflammation. American journal of respiratory and critical care medicine, 2001. 164(supplement_2): p. S39-S45.
Chakraborty, R.K. and K.M. Baradhi, Aspergilloma. StatPearls [Internet], 2020.
Andersen, P.E., Imaging and interventional radiological treatment of hemoptysis. Acta Radiologica, 2006. 47(8): p. 780-792.
Boulay, F., et al., Seasonal variation in cryptogenic and noncryptogenic hemoptysis hospitalizations in France. Chest, 2000. 118(2): p. 440-444.
Menchini, L., et al., Cryptogenic haemoptysis in smokers: angiography and results of embolisation in 35 patients. European Respiratory Journal, 2009. 34(5): p. 1031-1039.
Radchenko, C., A.H. Alraiyes, and S. Shojaee, A systematic approach to the management of massive hemoptysis. Journal of thoracic disease, 2017. 9(Suppl 10): p. S1069.
Reisz, G., et al., The causes of hemoptysis revisited. A review of the etiologies of hemoptysis between 1986 and 1995. Missouri medicine, 1997. 94(10): p. 633-635.
Kiral, H., et al., Pulmonary resection in the treatment of life-threatening hemoptysis. Annals of Thoracic and Cardiovascular Surgery, 2015: p. oa. 14-00164.
Kvale, P.A., P.A. Selecky, and U.B. Prakash, Palliative care in lung cancer: ACCP evidence-based clinical practice guidelines. Chest, 2007. 132(3): p. 368S-403S.
Cho, Y.-J., S.D. Murgu, and H.G. Colt, Bronchoscopy for bevacizumab-related hemoptysis. Lung Cancer, 2007. 56(3): p. 465-468.
Miller, R.R. and D.H. McGregor, Hemorrhage from carcinoma of the lung. Cancer, 1980. 46(1): p. 200-205.
Ito, M., et al., Risk factors associated with fatal pulmonary hemorrhage in locally advanced non-small cell lung cancer treated with chemoradiotherapy. BMC cancer, 2012. 12(1): p. 1-6.
Razazi, K., et al., Severe haemoptysis in patients with nonsmall cell lung carcinoma. European Respiratory Journal, 2015. 45(3): p. 756-764.
Gershman, E., et al., Management of hemoptysis in patients with lung cancer. Annals of translational medicine, 2019. 7(15).
Syabbalo, N., Hemoptysis: the third-world perspective. Chest, 1991. 99(5): p. 1316-1317.
Cuhadaroglu, C., et al., Increased risk of tuberculosis in health care workers: a retrospective survey at a teaching hospital in Istanbul, Turkey. BMC infectious diseases, 2002. 2(1): p. 1-4.
Chatterjee, K., et al., Rasmussen's aneurysm: a forgotten scourge. Respiratory medicine case reports, 2015. 16: p. 74-76.
Njoku, E., C. Okorafor, and F. Arimah, Hemoptysis: A symptom not well explored in the primary care setting in the developing world.
Faulkner, S.L., et al., Hemoptysis and pulmonary aspergilloma: operative versus nonoperative treatment. The Annals of thoracic surgery, 1978. 25(5): p. 389-392.
Young, V.K., et al., Operation for cavitating invasive pulmonary aspergillosis in immunocompromised patients. The Annals of thoracic surgery, 1992. 53(4): p. 621-624.
Garvey, J., et al., The surgical treatment of pulmonary aspergillomas. The Journal of thoracic and cardiovascular surgery, 1977. 74(4): p. 542-547.
Tekinbas, C., et al., Hydatid cyst disease of the lung as an unusual cause of massive hemoptysis: a case report. Journal of Medical Case Reports, 2009. 3(1): p. 1-3.
Uzun, O., T. Akpolat, and L. Erkan, Pulmonary vasculitis in Behçet disease. Chest, 2005. 127(6): p. 2243-2253.
Haponik, E.F., et al., Computed chest tomography in the evaluation of hemoptysis: impact on diagnosis and treatment. Chest, 1987. 91(1): p. 80-85.
Set, P., et al., Hemoptysis: comparative study of the role of CT and fiberoptic bronchoscopy. Radiology, 1993. 189(3): p. 677-680.
Chalumeau-Lemoine, L., et al., Impact of multidetector CT-angiography on the emergency management of severe hemoptysis. European journal of radiology, 2013. 82(11): p. e742-e747.
Hsiao, E.I., et al., Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. American Journal of Roentgenology, 2001. 177(4): p. 861-867.
Revel, M.P., et al., Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? American Journal of Roentgenology, 2002. 179(5): p. 1217-1224.
Mlllar, A., et al., The role of computed tomography (CT) in the investigation of unexplained haemoptysis. Respiratory medicine, 1992. 86(1): p. 39-44.
Khalil, A., et al., Utility of high-resolution chest CT scan in the emergency management of haemoptysis in the intensive care unit: severity, localization and aetiology. The British journal of radiology, 2007. 80(949): p. 21-25.
Gagnon, S., et al., Approach to hemoptysis in the modern era. Canadian respiratory journal, 2017. 2017.
Campos, J.H., et al., Devices for lung isolation used by anesthesiologists with limited thoracic experience: comparison of double-lumen endotracheal tube, Univent® torque control blocker, and Arndt wire-guided endobronchial blocker®. The Journal of the American Society of Anesthesiologists, 2006. 104(2): p. 261-266.
Campos, J.H., An update on bronchial blockers during lung separation techniques in adults. Anesthesia & Analgesia, 2003. 97(5): p. 1266-1274.
Bülbül, Y. and T. Özlü, Hemoptizide acil bronkoskopi. Bronkoskopi. Ankara: Poyraz, 2008: p. 391-8.
Saumench, J., et al., Value of fiberoptic bronchoscopy and angiography for diagnosis of the bleeding site in hemoptysis. The Annals of thoracic surgery, 1989. 48(2): p. 272-274.
Conlan, A.A. and S.S. Hurwitz, Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage. Thorax, 1980. 35(12): p. 901-904.
Davidson, K. and S. Shojaee, Managing massive hemoptysis. Chest, 2020. 157(1): p. 77-88.
Khoo, K.L., P. Lee, and A.C. Mehta, Endobronchial epinephrine: confusion is in the air. American journal of respiratory and critical care medicine, 2013. 187(10): p. 1137-1138.
Steinfort, D.P., et al., Potentially fatal arrhythmia complicating endobronchial epinephrine for control of iatrogenic bleeding. American journal of respiratory and critical care medicine, 2012. 185(9): p. 1028-1030.
Patel, S.R. and J.K. Stoller, 18 The Role of Bronchoscopy in Hemoptysis. Flexible Bronchoscopy, 2012: p. 250.
Valipour, A., et al., Bronchoscopy-guided topical hemostatic tamponade therapy for the management of life-threatening hemoptysis. Chest, 2005. 127(6): p. 2113-2118.
de Gracia, J., et al., Use of endoscopic fibrinogen–thrombin in the treatment of severe hemoptysis. Respiratory medicine, 2003. 97(7): p. 790-795.
BHATTACHARYYA, P., et al., Evaluation of the technical details of bronchoscopic endobronchial sealing: review of 67 patients. Indian journal of chest diseases & allied sciences, 2007. 49(3): p. 137-141.
Bellam, B.L., et al., Efficacy of tranexamic acid in haemoptysis: a randomized, controlled pilot study. Pulmonary pharmacology & therapeutics, 2016. 40: p. 80-83.
Wand, O., et al., Inhaled tranexamic acid for hemoptysis treatment: a randomized controlled trial. Chest, 2018. 154(6): p. 1379-1384.
Heslet, L., et al., Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Critical Care, 2006. 10(6): p. 1-6.
Bylicki, O., et al., Temporary endobronchial embolization with silicone spigots for moderate hemoptysis: a retrospective study. Respiration, 2012. 84(3): p. 225-230.
Lee, S.A. and G.S. Jeon, Covered bronchial stent insertion to manage airway obstruction with hemoptysis caused by lung cancer. Korean Journal of Radiology, 2012. 13(4): p. 515-520.
Sakr, L. and H. Dutau, Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration, 2010. 80(1): p. 38-58.
Kato, A., et al., Bronchial artery embolization for hemoptysis due to benign diseases: immediate and long-term results. Cardiovascular and interventional radiology, 2000. 23(5): p. 351-357.
Katoh, O., et al., Recurrent bleeding after arterial embolization in patients with hemoptysis. Chest, 1990. 97(3): p. 541-546.
Wang, G.R., et al., Bronchial artery embolization for the management of hemoptysis in oncology patients: utility and prognostic factors. Journal of Vascular and Interventional Radiology, 2009. 20(6): p. 722-729.
Lorenz, J., D. Sheth, and J. Patel. Bronchial artery embolization. in Seminars in interventional radiology. 2012. Thieme Medical Publishers.
Okumuş, N.G., et al., Bronşiyal arter embolizasyonun erken ve geç dönem sonuçları. Türk Göğüs Kalp Damar Cerrahisi Dergisi, 2010. 18(1): p. 23-26.
Garzon, A.A. and A. Gourin, Surgical management of massive hemoptysis. A ten-year experience. Ann Surg, 1978. 187(3): p. 267-71.
Andréjak, C., et al., Surgical Lung Resection for Severe Hemoptysis. The Annals of Thoracic Surgery, 2009. 88(5): p. 1556-1565.
Kiral, H., et al., Pulmonary Resection in the Treatment of Life-Threatening Hemoptysis. Annals of Thoracic and Cardiovascular Surgery, 2015. advpub.
Erdogan, A., et al., Surgical Management of Tuberculosis-Related Hemoptysis. The Annals of Thoracic Surgery, 2005. 79(1): p. 299-302.
Faulkner, S.L., et al., Hemoptysis and Pulmonary Aspergilloma: Operative versus Nonoperative Treatment. The Annals of Thoracic Surgery, 1978. 25(5): p. 389-392.
Demir, A., et al., Analysis of Surgical Treatment for Pulmonary Aspergilloma. Asian Cardiovascular and Thoracic Annals, 2006. 14(5): p. 407-411.
Tungözgür, B., et al., Dilemma on the Treatment of Haemoptysis: An Analysis of 249 Patients. Acta Chirurgica Belgica, 2007. 107(3): p. 302-306.
Dhaliwal, R.S., et al., Role of physiological lung exclusion in difficult lung resections for massive hemoptysis and other problems✩. European Journal of Cardio-Thoracic Surgery, 2001. 20(1): p. 25-29.
Metin, M., et al., Physiological exclusion for massive hemoptysis: when? European Journal of Cardio-Thoracic Surgery, 2001. 20(5): p. 1065-1065.
